Literature DB >> 2311308

Effects of a gluten-free diet in primary IgA nephropathy.

R Coppo1, D Roccatello, A Amore, G Quattrocchio, A Molino, B Gianoglio, A Amoroso, P Bajardi, G Piccoli.   

Abstract

In an uncontrolled study a gluten-free diet was given to 29 patients affected by primary IgA nephropathy (IgAGN). All of them followed the diet for 6 months, 23 patients for 1 year and 9 for 2 to 4 years. Mean levels of IgA containing circulating immune complexes (IgAIC), detected by a specific conglutinin assay and by measuring IgA content in 2.5% polyethylene glycol precipitates, on an unrestricted diet, significantly decreased after 6 months of gluten-free diet (p less than 0.01) and remained reduced during the follow-up. A decrease in IgAIC levels was evident in 85.7% of the cases with basal positive data, with complete normalization in 64.3% of them. IgA to gluten antigens (ethanol- or saline-soluble gliadin, glutenin and the lectin fraction termed glyc-gli) as well as to heterologous bovine and egg albumins were found to be significantly increased on an unrestricted diet in the group of 14 IgAGN patients with basal positive IgAIC. The mean levels of IgA to most dietary antigens significantly decreased after 6 months to 1 year of a gluten-free diet. A decrease in IgA to ethanol-soluble gliadin was evident in 81.8% of the cases with basal positive data, with complete normalization in 63.6%. A subgroup of 27.5% of IgAGN patients showed positive IgAIC values associated with increased IgA values to a variety of dietary antigens. A gluten-free diet induced in 75% of the cases a parallel improvement in these abnormal immunological data. Mean proteinuria values were found to be significantly decreased after 6 months of the diet and a reduction was also observed in microscopic hematuria. However, mean blood creatinine levels showed a significant increase after the gluten-free diet. The data of this study indicate that a gluten-free diet can modify some immunological abnormalities in a group of IgAGN patients, reducing levels of IgAIC and IgA to dietary antigens. The clinical course does not seem to be favorably influenced, since a relentless progression towards renal failure was observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311308

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  21 in total

Review 1.  Dysfunctions of the Iga system: a common link between intestinal and renal diseases.

Authors:  Christina Papista; Laureline Berthelot; Renato C Monteiro
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Immune response of tonsillar lymphocytes to Haemophilus parainfluenzae in patients with IgA nephropathy.

Authors:  S Suzuki; S Fujieda; H Sunaga; H Sugimoto; C Yamamoto; H Kimura; T Abo; F Gejyo
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

3.  Do IgA antigliadin and IgA antiendomysium antibodies show there is latent coeliac disease in primary IgA nephropathy?

Authors:  C Sategna-Guidetti; G Ferfoglia; M Bruno; R Pulitano; D Roccatello; A Amore; R Coppo
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

Review 4.  The epipharynx-kidney axis triggers glomerular vasculitis in immunoglobulin A nephropathy.

Authors:  Osamu Hotta; Takashi Oda
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

Review 5.  The mucosa-kidney axis in IgA nephropathy.

Authors:  Jürgen Floege; John Feehally
Journal:  Nat Rev Nephrol       Date:  2015-12-30       Impact factor: 28.314

6.  IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy.

Authors:  Sebastian M Lechner; Lilia Abbad; Erwan Boedec; Christina Papista; Marie-Bénédicte Le Stang; Christelle Moal; Julien Maillard; Agnès Jamin; Julie Bex-Coudrat; Yong Wang; Aiqun Li; Paolo G V Martini; Renato C Monteiro; Laureline Berthelot
Journal:  J Am Soc Nephrol       Date:  2016-02-05       Impact factor: 10.121

Review 7.  Role of IgA receptors in the pathogenesis of IgA nephropathy.

Authors:  Sebastian M Lechner; Christina Papista; Jonathan M Chemouny; Laureline Berthelot; Renato C Monteiro
Journal:  J Nephrol       Date:  2015-11-14       Impact factor: 3.902

Review 8.  New perspectives in treatment of glomerulonephritis.

Authors:  Rosanna Coppo; Alessandro Amore
Journal:  Pediatr Nephrol       Date:  2003-12-13       Impact factor: 3.714

9.  Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy.

Authors:  R Coppo; R Camilla; A Amore; L Peruzzi; V Daprà; E Loiacono; S Vatrano; C Rollino; V Sepe; T Rampino; A Dal Canton
Journal:  Clin Exp Immunol       Date:  2009-11-05       Impact factor: 4.330

10.  Gluten and IgA nephropathy: you are what you eat?

Authors:  Chee Kay Cheung; Jonathan Barratt
Journal:  Kidney Int       Date:  2015-08       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.